- Home
- MRUS vs IEP Comparison
MRUS vs IEP Comparison
Compare MRUS & IEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- IEP
- Stock Information
- Founded
- MRUS 2003
- IEP 1987
- Country
- MRUS Netherlands
- IEP United States
- Employees
- MRUS N/A
- IEP N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- IEP Auto Parts:O.E.M.
- Sector
- MRUS Health Care
- IEP Consumer Discretionary
- Exchange
- MRUS Nasdaq
- IEP Nasdaq
- Market Cap
- MRUS 5.1B
- IEP 4.7B
- IPO Year
- MRUS 2016
- IEP 1987
- Fundamental
- Price
- MRUS $96.19
- IEP $8.12
- Analyst Decision
- MRUS Buy
- IEP
- Analyst Count
- MRUS 17
- IEP 0
- Target Price
- MRUS $94.94
- IEP N/A
- AVG Volume (30 Days)
- MRUS 1.3M
- IEP 1.4M
- Earning Date
- MRUS 10-31-2025
- IEP 11-05-2025
- Dividend Yield
- MRUS N/A
- IEP 24.63%
- EPS Growth
- MRUS N/A
- IEP N/A
- EPS
- MRUS N/A
- IEP N/A
- Revenue
- MRUS $56,606,000.00
- IEP $9,257,000,000.00
- Revenue This Year
- MRUS $52.81
- IEP N/A
- Revenue Next Year
- MRUS N/A
- IEP $0.69
- P/E Ratio
- MRUS N/A
- IEP N/A
- Revenue Growth
- MRUS 57.54
- IEP N/A
- 52 Week Low
- MRUS $33.19
- IEP $7.27
- 52 Week High
- MRUS $96.28
- IEP $11.18
- Technical
- Relative Strength Index (RSI)
- MRUS 72.69
- IEP 47.81
- Support Level
- MRUS $95.74
- IEP $8.72
- Resistance Level
- MRUS $96.18
- IEP $9.10
- Average True Range (ATR)
- MRUS 0.36
- IEP 0.26
- MACD
- MRUS -0.39
- IEP -0.06
- Stochastic Oscillator
- MRUS 89.43
- IEP 34.62
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About IEP Icahn Enterprises L.P.
Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.